Understanding Normal and Malignant Human Hematopoiesis Using Next-Generation Humanized Mice.

human hematopoiesis human immunity humanized mouse leukemia xenograft

Journal

Trends in immunology
ISSN: 1471-4981
Titre abrégé: Trends Immunol
Pays: England
ID NLM: 100966032

Informations de publication

Date de publication:
08 2020
Historique:
received: 09 08 2019
revised: 12 06 2020
accepted: 14 06 2020
pubmed: 8 7 2020
medline: 17 3 2021
entrez: 8 7 2020
Statut: ppublish

Résumé

Rodent models for human diseases contribute significantly to understanding human physiology and pathophysiology. However, given the accelerating pace of drug development, there is a crucial need for in vivo preclinical models of human biology and pathology. The humanized mouse is one tool to bridge the gap between traditional animal models and the clinic. The development of immunodeficient mouse strains with high-level engraftment of normal and diseased human immune/hematopoietic cells has made in vivo functional characterization possible. As a patient-derived xenograft (PDX) model, humanized mice functionally correlate putative mechanisms with in vivo behavior and help to reveal pathogenic mechanisms. Combined with single-cell genomics, humanized mice can facilitate functional precision medicine such as risk stratification and individually optimized therapeutic approaches.

Identifiants

pubmed: 32631635
pii: S1471-4906(20)30128-9
doi: 10.1016/j.it.2020.06.004
pmc: PMC7395895
mid: NIHMS1605400
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

706-720

Subventions

Organisme : NIH HHS
ID : R24 OD026440
Pays : United States
Organisme : NCI NIH HHS
ID : R37 CA237307
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK104218
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI132963
Pays : United States
Organisme : NIDDK NIH HHS
ID : UC4 DK104218
Pays : United States

Informations de copyright

Copyright © 2020 Elsevier Ltd. All rights reserved.

Références

Cancer Immunol Res. 2019 Aug;7(8):1267-1279
pubmed: 31186248
J Exp Med. 2016 Jul 25;213(8):1513-35
pubmed: 27377587
PLoS One. 2018 Dec 12;13(12):e0209034
pubmed: 30540841
Cell Host Microbe. 2009 Jul 23;6(1):5-9
pubmed: 19616761
Science. 2020 Mar 27;367(6485):1449-1454
pubmed: 32217721
Sci Transl Med. 2017 Oct 25;9(413):
pubmed: 29070697
Nat Rev Immunol. 2012 Nov;12(11):786-98
pubmed: 23059428
J Immunol. 2010 Apr 1;184(7):3562-9
pubmed: 20207995
Life Sci Alliance. 2019 Apr 1;2(2):
pubmed: 30936185
Proc Natl Acad Sci U S A. 1995 Jan 17;92(2):377-81
pubmed: 7831294
Leukemia. 2010 Oct;24(10):1785-8
pubmed: 20686503
J Clin Invest. 2018 Jul 2;128(7):2862-2876
pubmed: 29863499
Oncoimmunology. 2018 Oct 29;8(2):e1532763
pubmed: 30713786
Ann Oncol. 2017 Oct 1;28(10):2595-2605
pubmed: 28945830
PLoS One. 2019 Sep 19;14(9):e0217345
pubmed: 31536492
Nat Commun. 2019 Jun 3;10(1):2395
pubmed: 31160568
Front Immunol. 2019 Feb 04;10:63
pubmed: 30778347
Ann N Y Acad Sci. 2011 Dec;1245:50-4
pubmed: 22211979
Oncoimmunology. 2018 Apr 18;7(8):e1450715
pubmed: 30221044
J Infect Dis. 2018 Nov 22;218(suppl_5):S409-S417
pubmed: 30085162
Haematologica. 2016 Jan;101(1):5-19
pubmed: 26721800
Oncoimmunology. 2019 Apr 12;8(7):1596005
pubmed: 31143518
Proc Natl Acad Sci U S A. 2011 Aug 9;108(32):13218-23
pubmed: 21788509
Nat Biotechnol. 2014 Apr;32(4):364-72
pubmed: 24633240
Nat Methods. 2018 Aug;15(8):623-630
pubmed: 30065364
Int J Oncol. 2009 Mar;34(3):657-63
pubmed: 19212670
Oncoimmunology. 2017 May 11;6(8):e1320630
pubmed: 28919991
Leukemia. 2010 Nov;24(11):1859-66
pubmed: 20739953
Proc Natl Acad Sci U S A. 1996 Sep 17;93(19):10285-90
pubmed: 8816792
Trends Immunol. 2018 Oct;39(10):775-787
pubmed: 30150089
Immunity. 2017 Oct 17;47(4):680-696.e8
pubmed: 29045900
Science. 2011 Jul 8;333(6039):218-21
pubmed: 21737740
Oncoimmunology. 2019 May 27;8(8):1593804
pubmed: 31413905
Proc Natl Acad Sci U S A. 2011 Aug 9;108(32):13224-9
pubmed: 21788504
Trends Immunol. 2017 May;38(5):345-357
pubmed: 28216309
J Exp Med. 2005 Nov 21;202(10):1307-11
pubmed: 16301740
Nat Rev Immunol. 2007 Feb;7(2):118-30
pubmed: 17259968
Nat Biotechnol. 2019 Oct;37(10):1163-1173
pubmed: 31451733
Lung Cancer. 2019 Jan;127:112-121
pubmed: 30642538
J Immunol Methods. 2014 Aug;410:3-17
pubmed: 24607601
J Immunol. 2012 Jun 15;188(12):6145-55
pubmed: 22611244
Blood. 1996 Feb 1;87(3):956-67
pubmed: 8562967
Nat Immunol. 2009 Oct;10(10):1039-42
pubmed: 19767720
Nature. 2017 Jul 6;547(7661):104-108
pubmed: 28658204
Nat Med. 2019 Dec;25(12):1916-1927
pubmed: 31792460
Clin Exp Immunol. 2008 Nov;154(2):270-84
pubmed: 18785974
Leukemia. 2019 May;33(5):1113-1123
pubmed: 30568172
J Exp Med. 2009 Jun 8;206(6):1423-34
pubmed: 19487422
Cancer Cell. 2016 Apr 11;29(4):574-586
pubmed: 27070704
Nucleic Acids Res. 2019 Sep 5;47(15):7955-7972
pubmed: 31147717
Sci Transl Med. 2012 Aug 29;4(149):149ra118
pubmed: 22932223
Nat Rev Immunol. 2006 Jun;6(6):457-64
pubmed: 16691243
Stem Cell Reports. 2016 Oct 11;7(4):591-601
pubmed: 27618723
Blood. 2017 Jul 27;130(4):397-407
pubmed: 28576879
Curr Opin HIV AIDS. 2018 Mar;13(2):143-151
pubmed: 29194124
Cell Stem Cell. 2019 Nov 7;25(5):639-653.e7
pubmed: 31631013
Science. 2004 Apr 2;304(5667):104-7
pubmed: 15064419
Biochem Biophys Res Commun. 2017 Dec 9;494(1-2):13-19
pubmed: 29061300
J Immunol. 2005 May 15;174(10):6477-89
pubmed: 15879151
Nat Biotechnol. 2011 Oct 02;29(10):928-33
pubmed: 21964413
Mol Ther Methods Clin Dev. 2016 Dec 07;3:16083
pubmed: 27933310
Exp Hematol. 2020 Mar;83:48-56
pubmed: 31838005
Cancer Immunol Res. 2019 Jan;7(1):150-161
pubmed: 30459153
Blood. 2005 Sep 1;106(5):1565-73
pubmed: 15920010
Proc Natl Acad Sci U S A. 2014 Feb 18;111(7):2548-53
pubmed: 24550281
Blood. 2002 Nov 1;100(9):3175-82
pubmed: 12384415
Gut. 2018 Oct;67(10):1845-1854
pubmed: 29602780
Oncotarget. 2017 Aug 3;8(35):57964-57980
pubmed: 28938530
Immunity. 2007 May;26(5):643-54
pubmed: 17521585
Clin Cancer Res. 2017 Jan 1;23(1):149-158
pubmed: 27458246
Cancer Discov. 2019 Dec;9(12):1754-1773
pubmed: 31699796
J Exp Med. 1998 Aug 17;188(4):627-34
pubmed: 9705945
Nat Cell Biol. 2017 Apr;19(4):271-281
pubmed: 28319093
Nat Cell Biol. 2019 Jan;21(1):2-8
pubmed: 30602765
Cell. 2018 May 31;173(6):1535-1548.e16
pubmed: 29706549
Cancer Cell. 2018 Oct 8;34(4):674-689.e8
pubmed: 30245083
Nat Commun. 2017 Sep 27;8(1):707
pubmed: 28955032
Cancer Cell. 2014 Jun 16;25(6):794-808
pubmed: 24835589
Immunobiology. 1998 Feb;198(4):451-64
pubmed: 9562869
Blood. 2012 Mar 22;119(12):2778-88
pubmed: 22246028
Blood. 2011 Mar 17;117(11):3076-86
pubmed: 21252091
Stem Cells Dev. 2016 Apr 1;25(7):530-41
pubmed: 26879149
Nat Commun. 2018 Oct 8;9(1):4156
pubmed: 30297889
Proc Natl Acad Sci U S A. 2017 Nov 7;114(45):E9626-E9634
pubmed: 29078283
Am J Transplant. 2016 Feb;16(2):389-97
pubmed: 26588186
Cell. 1992 Mar 6;68(5):869-77
pubmed: 1547488
Sci Rep. 2017 Dec 8;7(1):17230
pubmed: 29222435
Annu Rev Pathol. 2017 Jan 24;12:187-215
pubmed: 27959627
J Immunol Res. 2016;2016:2414906
pubmed: 27872864
Oncoimmunology. 2019 Mar 16;8(5):e1581556
pubmed: 31069145
Int Immunol. 2012 Apr;24(4):243-52
pubmed: 22402880
Nat Commun. 2018 Jun 5;9(1):2175
pubmed: 29872044
AIDS Res Hum Retroviruses. 2016 Feb;32(2):109-19
pubmed: 26670361
J Immunother Cancer. 2019 Feb 8;7(1):37
pubmed: 30736857
Curr Opin Immunol. 2013 Jun;25(3):403-9
pubmed: 23628166
Science. 1988 Sep 23;241(4873):1632-9
pubmed: 2971269
Blood. 2013 Feb 21;121(8):1316-25
pubmed: 23293079
Cancer Cell. 2019 Aug 12;36(2):123-138.e10
pubmed: 31303423
Nat Commun. 2019 Jan 21;10(1):366
pubmed: 30664659
J Cell Physiol. 2018 May;233(5):3723-3728
pubmed: 28598567
Sci Transl Med. 2012 Mar 14;4(125):125ra30
pubmed: 22422991
Nat Commun. 2018 Oct 5;9(1):4100
pubmed: 30291229
FASEB J. 2019 Mar;33(3):3137-3151
pubmed: 30383447
Exp Hematol. 2018 Nov;67:18-31
pubmed: 30125602
Front Immunol. 2018 Jan 17;8:2017
pubmed: 29387068
Nature. 2020 Feb;578(7793):160-165
pubmed: 31969707
Nature. 2014 Feb 20;506(7488):328-33
pubmed: 24522528
J Clin Invest. 2019 May 1;129(5):2071-2087
pubmed: 31042161
J Infect Dis. 2013 Nov;208 Suppl 2:S125-30
pubmed: 24151318
Cell. 1992 Mar 6;68(5):855-67
pubmed: 1547487
Immunity. 1995 Mar;2(3):223-38
pubmed: 7697543
Nat Med. 1998 Sep;4(9):1038-45
pubmed: 9734397
Nat Med. 2006 Nov;12(11):1316-22
pubmed: 17057712
Nat Med. 2016 Jul;22(7):812-21
pubmed: 27213817
Nature. 1994 Feb 17;367(6464):645-8
pubmed: 7509044
Curr Opin Endocrinol Diabetes Obes. 2010 Apr;17(2):120-5
pubmed: 20150806
J Clin Endocrinol Metab. 2020 Jan 1;105(1):
pubmed: 31513709
Nat Protoc. 2017 Oct;12(10):2169-2188
pubmed: 28933777
Trends Cell Biol. 2001 Mar;11(3):130-5
pubmed: 11306274
Leukemia. 2007 Jan;21(1):136-42
pubmed: 17039228
Blood. 2013 Jan 31;121(5):e1-4
pubmed: 23233660
Cancer Immunol Res. 2019 Jul;7(7):1120-1134
pubmed: 31164357
Nat Med. 2003 Jul;9(7):959-63
pubmed: 12796774
J Immunol. 1995 Jan 1;154(1):180-91
pubmed: 7995938
Science. 2016 Jan 8;351(6269):aab2116
pubmed: 26541609
Nat Biotechnol. 2007 Nov;25(11):1315-21
pubmed: 17952057
Blood. 2012 Mar 22;119(12):2768-77
pubmed: 22279057
Blood Adv. 2017 Apr 06;1(10):601-614
pubmed: 29296702
Cell Rep. 2018 Aug 28;24(9):2329-2341.e8
pubmed: 30157427
Mucosal Immunol. 2012 Sep;5(5):555-66
pubmed: 22569301
Nat Cell Biol. 2018 Jul;20(7):836-846
pubmed: 29915358
Mamm Genome. 2019 Jun;30(5-6):123-142
pubmed: 30847553
Annu Rev Immunol. 2013;31:635-674
pubmed: 23330956
Cell Stem Cell. 2007 Dec 13;1(6):635-45
pubmed: 18371405
J Exp Med. 1999 Oct 18;190(8):1059-68
pubmed: 10523604
J Exp Med. 2009 Jan 16;206(1):25-34
pubmed: 19103877
Clin Cancer Res. 2019 Aug 1;25(15):4761-4774
pubmed: 31068371
Immunity. 2019 Mar 19;50(3):738-750.e7
pubmed: 30770248
Exp Hematol. 2015 Dec;43(12):989-92
pubmed: 26455528
Nat Commun. 2018 Jul 16;9(1):2741
pubmed: 30013077
Nature. 2016 Dec 15;540(7633):433-437
pubmed: 27926740
Nat Immunol. 2018 Jan;19(1):85-97
pubmed: 29167569
Nature. 1983 Feb 10;301(5900):527-30
pubmed: 6823332
Proc Natl Acad Sci U S A. 2018 May 8;115(19):E4453-E4462
pubmed: 29674449
Blood. 2017 Jun 22;129(25):3332-3343
pubmed: 28336526
Proc Natl Acad Sci U S A. 2010 Jul 20;107(29):13022-7
pubmed: 20615947
Science. 1988 Dec 23;242(4886):1706-9
pubmed: 2904703
Nature. 1988 Sep 15;335(6187):256-9
pubmed: 2970594
Immunol Lett. 2004 Feb 15;91(2-3):79-86
pubmed: 15019273
Leukemia. 1997 Apr;11 Suppl 3:109-12
pubmed: 9209314
PLoS One. 2019 Nov 20;14(11):e0225532
pubmed: 31747424
Int J Hematol. 2005 Dec;82(5):389-96
pubmed: 16533740
Cold Spring Harb Protoc. 2014 Jul 01;2014(7):694-708
pubmed: 24987146
Proc Natl Acad Sci U S A. 2015 Nov 3;112(44):E6020-7
pubmed: 26483497
Nat Med. 2018 Jun;24(6):739-748
pubmed: 29808007
Cell Host Microbe. 2020 Apr 8;27(4):642-658.e12
pubmed: 32109369
Stem Cell Reports. 2016 Sep 13;7(3):425-438
pubmed: 27499200
PLoS One. 2017 Jun 15;12(6):e0179239
pubmed: 28617827
PLoS One. 2014 Feb 06;9(2):e88205
pubmed: 24516613
Clin Cancer Res. 2019 Apr 15;25(8):2610-2620
pubmed: 30647079

Auteurs

Yoriko Saito (Y)

RIKEN Center for Integrative Medical Sciences, Yokohama City, Kanagawa, 230-0045, Japan.

Leonard D Shultz (LD)

The Jackson Laboratory, Bar Harbor, ME 04609, USA.

Fumihiko Ishikawa (F)

RIKEN Center for Integrative Medical Sciences, Yokohama City, Kanagawa, 230-0045, Japan. Electronic address: fumihiko.ishikawa@riken.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH